Bigelow Investment Advisors LLC Decreases Position in The Clorox Company (NYSE:CLX)

Bigelow Investment Advisors LLC reduced its stake in The Clorox Company (NYSE:CLX) by 5.2% during the 1st quarter, HoldingsChannel.com reports. The firm owned 1,724 shares of the company’s stock after selling 95 shares during the period. Bigelow Investment Advisors LLC’s holdings in Clorox were worth $254,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Redwood Park Advisors LLC acquired a new position in Clorox in the fourth quarter valued at $26,000. Millstone Evans Group LLC acquired a new stake in shares of Clorox during the fourth quarter worth about $31,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox in the 4th quarter valued at about $31,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Clorox in the 4th quarter valued at about $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in Clorox during the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 1.1%

Shares of NYSE:CLX opened at $120.77 on Thursday. The Clorox Company has a fifty-two week low of $120.69 and a fifty-two week high of $171.37. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The firm’s 50-day simple moving average is $133.92 and its 200-day simple moving average is $147.55. The company has a market cap of $14.88 billion, a price-to-earnings ratio of 21.68, a PEG ratio of 2.76 and a beta of 0.54.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the business earned $1.71 EPS. Clorox’s revenue for the quarter was down 8.0% on a year-over-year basis. As a group, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Insider Activity

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the business’s stock in a transaction on Wednesday, May 7th. The stock was purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the transaction, the director now owns 4,000 shares of the company’s stock, valued at $546,280. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Citigroup reduced their price objective on Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Wells Fargo & Company cut their target price on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. UBS Group decreased their price target on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research note on Thursday, April 17th. Morgan Stanley lowered their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Finally, Barclays reduced their target price on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a report on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $151.23.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.